Protalix BioTherapeutics ... (PLX)
AMEX: PLX
· Real-Time Price · USD
2.43
0.09 (3.85%)
At close: Oct 03, 2025, 3:59 PM
13F Institute Ownership
Total Institutes of 65 in Protalix BioTherapeutics reduced their positions with a decrease of 3 investors compared to the previous quarter. An additional 3.72M shares, as total invested capital declined by $3.33M with ownership percentage increasing from 11.29% to 15.54%.
Options Activity
Institutions are holding more Calls Contracts as Puts Contracts, indicating a bullish sentiment.
Put/Call 0.187
0.19
Call Flow 167,900
84%
Put Flow 31,400
16%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio | Filing Date |
|---|---|---|---|---|---|---|
| Blackrock, Inc. | 4.40% | 3.37M | +1.22K% | 4.99M | < 0.01% | Aug 12, 2025 |
| Renaissance Technologies LLC | 2.11% | 1.62M | +35.83% | 2.39M | < 0.01% | Aug 13, 2025 |
| Northern Trust Corp | 1.41% | 1.08M | +57.68% | 1.6M | < 0.01% | Aug 13, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.